ConsumerLab RYR Supplements Review: A different red yeast rice
A CL member asked about a newer type of red yeast rice known as ANKASCIN 568-R Plus. ConsumerLab added information about it to its Red Yeast Rice Review.
Ankascin 568-R Plus
A very different type of red yeast rice product on the market is Ankascin 568-R Plus (Sunway Biotech Co., Ltd., Taiwan), which contains an extract of red yeast rice focusing on two compounds, ankaflavin and monascin, as opposed to the lovastatin compounds normally in red yeast rice products. It is a certified health food in Taiwan for regulating lipid function and to assist in regulating blood glucose function. It was accepted by the U.S. FDA as a new dietary ingredient in 2018 (which does not mean that it is effective, but that the FDA has not expressed safety concerns).
An 8-week, placebo-controlled (but not double-blinded) study in Taiwan among 40 people with metabolic
syndrome found no negative effects of Ankascin 568-Plus (500 mg daily) on liver, kidney, or thyroid function, nor any indication of muscle breakdown. There was no significant decrease in fasting blood glucose or triglyceride levels compared to placebo, but there was a 19% decrease in LDL cholesterol versus a 1.9% decrease with placebo. Although funding of the study was not disclosed, one of the study authors is employed by Sunway Biotch (Liu, J Food Drug Analysis 2018). It would seem reasonable to await additional, objective, clinical research for this supplement before using.
Ask us for more details!